Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress.
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
[Cognitive impairment in demyelinating disease].
Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: A meta-analysis of 6977 subjects.
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.
Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications
Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis.
No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Fatal Neuroinflammation in a Case of Multiple Sclerosis with Anti-Natalizumab Antibodies.
Functional role of TRP channels in modulating ER stress and Autophagy.
The "liberation procedure" for multiple sclerosis: sacrificing science at the altar of consumer demand.
Alteration of CD1 expression in multiple sclerosis.
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.
Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study.
What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.
Symptom overlap in anxiety and multiple sclerosis.
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
Juxtacortical Lesions in Multiple Sclerosis: Assessment of Gray Matter Involvement Using Phase Difference-enhanced Imaging (PADRE).
Individual variability in speed of information processing: An index of cognitive impairment in multiple sclerosis.
The effect of supported standing in adults with upper motor neurone disorders: a systematic review.
Recommendations for diagnosis and management of multiple sclerosis.
Pages
« first
‹ previous
…
132
133
134
135
136
137
138
139
140
…
next ›
last »